封面
市場調查報告書
商品編碼
1488038

數位聽診器市場 - 按產品類型(放大、數位化)、技術(整合胸件系統、無線傳輸系統)、應用(普通醫學、心臟病學、呼吸系統、兒科)、最終用途和預測,2024 - 2032 年

Digital Stethoscope Market - By Product Type (Amplifying, Digitalization), Technology (Integrated Chest-Piece System, Wireless Transmission System), Application (General Medicine, Cardiology, Respiratory, Pediatric), End-Use & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

數位聽診器市場規模預計從 2024 年到 2032 年複合年成長率為資料 %。 。

全球心血管疾病和呼吸系統疾病的盛行率不斷上升,推動了對數位聽診器等先進診斷工具的需求。根據疾病預防控制中心 (CDC) 的數據,美國每年約有 805,000 人患有心臟病。數位聽診器在各種慢性疾病的早期檢測和診斷中發揮著至關重要的作用,增加了人們的需求。

在 COVID-19 大流行期間,遠距醫療和遠距患者監護解決方案的日益普及也為市場成長提供了動力。政府和醫療保健組織發起的旨在實現醫療保健基礎設施現代化和改善醫療設備取得的舉措將進一步提升這些聽診器的吸引力。

整個產業分為產品類型、技術、應用、最終用途和地區。

就產品類型而言,由於對增強聽診功能的需求不斷成長,預計從 2024 年到 2032 年,放大聽診器領域的數位聽診器市場將以 5.6% 的複合年成長率成長。擴音聽診器提供改進的聲音放大和降噪功能,可幫助醫療保健專業人員更好地檢測和診斷微妙的心臟和呼吸音。數位技術的整合還增強了便利性,可以輕鬆傳輸聽診資料以進行分析和諮詢。

在應用方面,由於兒童對準確和非侵入性診斷工具的需求不斷成長,預計到 2032 年,兒科應用領域的數位聽診器市場將以 6.1% 的複合年成長率成長。數位聽診器提供兒科特有的功能,例如可調頻率設定和較小的胸部零件,確保兒科患者聽診更舒適、更有效。捕獲和儲存數位聽診記錄的能力也促進了醫療保健提供者之間的協作,以實現遠端諮詢,從而促進了該細分市場的成長。

從地區來看,歐洲數位聽診器產業規模預計在預測期內將成長 5.1%。這可以歸因於人口老化、心血管和呼吸系統疾病盛行率的增加以及醫療保健的進步。遠距醫療和遠距患者監護解決方案的採用,以及政府推出的醫療基礎設施現代化舉措正在推動區域市場的發展。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率增加
      • 數位聽診器的技術進步
      • 擴大採用遠距諮詢實踐
    • 產業陷阱與挑戰
      • 產品成本高
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 政策格局
  • 未來市場趨勢

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2018 年 - 2032 年

  • 主要趨勢
  • 擴音聽診器
  • 數位化聽診器

第 6 章:市場估計與預測:按技術分類,2018 - 2032 年

  • 主要趨勢
  • 整合胸件系統
  • 無線傳輸系統
  • 整合接收頭件系統

第 7 章:市場估計與預測:按應用分類,2018 年 - 2032 年

  • 主要趨勢
  • 一般用藥
  • 心臟病學
  • 呼吸系統
  • 兒科
  • 其他應用

第 8 章:市場估計與預測:依最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心
  • 家庭護理設置
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • 3M Company
  • Ayu Devices
  • Contec Medical Systems
  • Eko Health Inc.
  • Ekuore
  • FarmaSino Pharmaceuticals
  • GS Technology Co., Ltd.
  • Medline Industries Inc.
  • Rudolf Riester GmbH
  • Think Labs Medical LLC
簡介目錄
Product Code: 8581

Digital Stethoscope Market size is estimated to depict 5.9% CAGR from 2024 to 2032. Significant advancements are leading to the development of digital stethoscopes with enhanced features, such as noise cancellation, Bluetooth connectivity, and real-time data recording for improving diagnostic accuracy and efficiency.

The increasing prevalence of cardiovascular diseases and respiratory disorders worldwide is driving the demand for advanced diagnostic tools like digital stethoscopes. As per the CDC, every year about 805,000 people in the U.S. suffer a heart attack. Digital stethoscopes play a crucial role in the early detection and diagnosis of various chronic diseases, adding to their demand.

The growing adoption of telemedicine and remote patient monitoring solutions during the COVID-19 pandemic also provided an impetus for the market growth. The launch of initiatives by governments and healthcare organizations to modernize healthcare infrastructure and to improve access to medical devices will further escalate the appeal of these stethoscopes.

The overall industry is segregated into product type, technology, application, end-use, and region.

In terms of product type, the digital stethoscope market from the amplifying stethoscope segment is projected to expand at 5.6% CAGR from 2024 to 2032, owing to the growing demand for enhanced auscultation capabilities. Amplifying stethoscopes offer improved sound amplification and noise reduction features to assist healthcare professionals to better detect and diagnose subtle cardiac and respiratory sounds. The integration of digital technologies is also enhancing convenience and enabling easy transmission of auscultation data for analysis and consultation.

With respect to application, the digital stethoscope market from the pediatric application segment is projected to grow at 6.1% CAGR through 2032, driven by the rising need for accurate and non-invasive diagnostic tools for children. Digital stethoscopes provide pediatric-specific features, such as adjustable frequency settings and smaller chest pieces, ensuring more comfortable and effective auscultation in pediatric patients. The ability to capture and store digital auscultation recordings is also facilitating collaboration among healthcare providers for enabling remote consultations, adding to the segment growth.

Regionally, the Europe digital stethoscope industry size is anticipated to record 5.1% gains during the forecast period. This can be attributed to the aging population, increasing prevalence of cardiovascular and respiratory diseases, and advancements in healthcare. The adoption of telemedicine and remote patient monitoring solutions, along with the launch of government initiatives to modernize healthcare infrastructure is boosting the regional market progression.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Technological advancements in digital stethoscope
      • 3.2.1.3 Growing adoption of of teleconsultation practices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High product cost
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Policy landscape
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Amplifying stethoscope
  • 5.3 Digitalization stethoscope

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Integrated chest-piece system
  • 6.3 Wireless transmission system
  • 6.4 Integrated receiver head-piece system

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 General medicine
  • 7.3 Cardiology
  • 7.4 Respiratory
  • 7.5 Pediatric
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Home care settings
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 3M Company
  • 10.2 Ayu Devices
  • 10.3 Contec Medical Systems
  • 10.4 Eko Health Inc.
  • 10.5 Ekuore
  • 10.6 FarmaSino Pharmaceuticals
  • 10.7 GS Technology Co., Ltd.
  • 10.8 Medline Industries Inc.
  • 10.9 Rudolf Riester GmbH
  • 10.10 Think Labs Medical LLC